Avantor (NYSE:AVTR) Posts Earnings Results, Beats Estimates By $0.02 EPS

Avantor (NYSE:AVTRGet Free Report) released its earnings results on Friday. The company reported $0.22 earnings per share for the quarter, topping analysts’ consensus estimates of $0.20 by $0.02, Briefing.com reports. Avantor had a net margin of 4.61% and a return on equity of 14.11%. The firm had revenue of $1.68 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same period in the prior year, the firm earned $0.29 earnings per share. The business’s quarterly revenue was down 5.6% compared to the same quarter last year.

Avantor Stock Performance

Shares of NYSE AVTR traded down $1.21 during midday trading on Friday, reaching $23.94. 14,185,165 shares of the company were exchanged, compared to its average volume of 4,145,237. The stock has a market cap of $16.24 billion, a P/E ratio of 49.88, a PEG ratio of 2.56 and a beta of 1.37. Avantor has a 1 year low of $16.63 and a 1 year high of $26.16. The stock has a fifty day simple moving average of $25.08 and a 200 day simple moving average of $22.61. The company has a current ratio of 1.61, a quick ratio of 1.05 and a debt-to-equity ratio of 1.00.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on the stock. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Avantor from $23.00 to $25.00 and gave the stock a “hold” rating in a research report on Thursday, April 18th. UBS Group upped their price objective on Avantor from $25.00 to $29.00 and gave the stock a “buy” rating in a research report on Thursday, February 15th. Raymond James raised their target price on Avantor from $22.50 to $26.00 and gave the stock an “outperform” rating in a research report on Friday, January 26th. Robert W. Baird upped their price target on Avantor from $25.00 to $26.00 and gave the company an “outperform” rating in a report on Thursday, February 15th. Finally, Royal Bank of Canada increased their price target on shares of Avantor from $28.00 to $29.00 and gave the company an “outperform” rating in a research note on Thursday, February 15th. Four research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $26.71.

View Our Latest Stock Analysis on AVTR

Insider Buying and Selling at Avantor

In related news, EVP James Bramwell sold 6,203 shares of the stock in a transaction on Tuesday, February 27th. The stock was sold at an average price of $24.49, for a total transaction of $151,911.47. Following the completion of the sale, the executive vice president now directly owns 101,143 shares of the company’s stock, valued at $2,476,992.07. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 1.50% of the stock is owned by company insiders.

About Avantor

(Get Free Report)

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

Recommended Stories

Earnings History for Avantor (NYSE:AVTR)

Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.